The high recurrence rates of Clostridioides difficile infection highlight the need for novel agents with unique mechanisms of action for treating the infection.
Ravina Kullar, PharmD, MPH, FIDSA*
Advertisement
Articles by Ravina Kullar, PharmD, MPH, FIDSA*
Advertisement
Latest Updated Articles
- Investigational Treatments for Clostridioides difficile Infection
October 10th 2019
Advertisement
Advertisement
Trending on Contagion Live
1
Cases of Cyclosporiasis Continue to Rise Across 31 States With Michigan Reporting Highest Numbers
2
Antiviral Being Used in Current Ebola Outbreak Advances Through Dual Development Strategy
3
New Single-Step Test Nearly Doubles Early Lyme Disease Detection
4
Nutrient-Limited Conditions May Dramatically Alter Antibiotic Effectiveness
5